K. Schiffman

Factors that influence collection and engraftment of autologous peripheral-blood stem cells.

R. Storb, F. Appelbaum, T. Gooley, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's disease.

D. Maloney, F. Appelbaum, T. Gooley, 1997, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: incidence, risk factors, and outcome.

Jung Lim Lee, T. Gooley, G. McDonald, 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Lymphocytic gastritis resembling graft-vs.-host disease following autologous hematopoietic cell transplantation.

D. Hockenbery, R. Hackman, S. Tzung, 1998, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Consequences of cryopreserving first remission autologous marrow for use after relapse in patients with acute myeloid leukemia.

R. Storb, F. Appelbaum, P. Martin, 1993, Bone marrow transplantation.

High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer

F. Appelbaum, W. Nichols, S. Petersdorf, 1997, Bone Marrow Transplantation.

High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma.

R. Storb, D. Maloney, F. Appelbaum, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Peripheral-blood stem-cell collections after paclitaxel, cyclophosphamide, and recombinant human granulocyte colony-stimulating factor in patients with breast and ovarian cancer.

R. Storb, F. Appelbaum, K. Schiffman, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease.

R. Storb, F. Appelbaum, T. Gooley, 1996, Bone marrow transplantation.

High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cells.

R. Storb, F. Appelbaum, P. Mcsweeney, 1996, Bone marrow transplantation.